Quantcast

Latest Fludeoxyglucose Stories

2009-01-26 06:00:00

BOSTON, Jan. 26 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced today that the United States Patent and Trademark Office issued U.S. Patent No. 7,438,891, covering methods of imaging cardiovascular plaque formation using F18 labeled 2-fluorodeoxy-D-glucose (FDG). This patent, exclusively licensed from the Massachusetts General Hospital, provides FluoroPharma with additional patent claims...

2009-01-06 12:00:00

Controlled FDG Delivery Study Uses Intego(TM) PET Infusion System to Compare Techniques for Patient Management WARRENDALE, Pa., Jan. 6 /PRNewswire/ -- MEDRAD, Inc., has signed a research agreement with the University of Zurich to study dynamic PET imaging with the MEDRAD Intego(TM) PET Infusion System. The researchers will utilize MEDRAD's latest technology to more precisely control the radioactive dose delivered during PET imaging procedures. (Logo:...

2008-10-17 15:00:23

HOUSTON, Oct. 17 /PRNewswire-USNewswire/ -- Early in 2008, the National Oncologic PET Registry (NOPR) published its initial results indicating that clinicians changed the intended care of more than one in three cancer patients as the result of FDG-PET scan findings. These findings were published on-line on March 24 in the Journal of Clinical Oncology (JCO). On March 25, the NOPR Working Group submitted a formal request to the Centers for Medicare and Medicaid Services (CMS), asking that it...

2008-09-24 09:00:13

By Herrmann, Ken Eckel, Florian; Schmidt, Stefan; Scheidhauer, Klemens; Krause, Bernd Joachim; Kleeff, Joerg; Schuster, Tibor; Wester, Hans- Juergen; Friess, Helmut; Schmid, Roland M; Schwaiger, Markus; Buck, Andreas K We have determined the ability of PET with the thymidine analog 3'-deoxy-3'-^sup 18^F-fluorothymidine (FLT) to detect pancreatic cancer and to differentiate malignant from benign pancreatic lesions. Methods: In this prospective study, ^sup 18^F-FLT PET was performed on 31...

2008-08-13 12:00:21

IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) the leading global provider of PET radiopharmaceuticals, and NST (NeuroSurvival Technologies Ltd.) the leading developer of agents targeting apoptosis (programmed cell death) for molecular imaging and therapy, today announced the signing of a collaboration agreement for radiolabeling and distributing APOSENSE(R) [18F]-ML-10, NST's novel agent for molecular imaging of apoptosis, to sites participating in multi-center...

2008-08-05 09:01:31

KENNEWICK, Wash., Aug. 5, 2008 (PRIME NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (Pink Sheets:ADMD) (http://www.isotopeworld.com) announced the initial delivery of short-lived radioisotopes to be used in Positron Emission Tomography (PET) from the Kennewick, Washington production center to Kadlec Medical Center of Richland, Washington. President William J. Stokes said, "AMIC is delighted to assist our region's health care needs and be a local source for the production of a...

2008-07-24 12:01:22

QuantRx Biomedical has announced that the company's FluoroPharma has achieved positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging. The Phase I trial was designed to evaluate safety, distribution and dosimetry of BFPET in 12 healthy subjects following a single dose injection at rest. BFPET is FluoroPharma's second cardiovascular product to complete Phase I clinical development. BFPET is a positron emission tomography (PET) imaging...

2008-06-30 15:02:49

CALGARY, ALBERTA--(Marketwire - June 30, 2008) - Fording Canadian Coal Trust (TSX:FDG.UN) (NYSE:FDG) will release its 2008 second quarter financial results on Wednesday, July 23, 2008 following the close of markets. Boyd Payne, President of Fording Canadian Coal Trust, will host a conference call with analysts to discuss the results on Thursday, July 24, 2008 at 7:30 a.m. MDT, 9:30 a.m. EST. Individual investors and the media are invited to participate in a listen-only mode. To...

2008-06-25 09:02:22

By Plathow, Christian Weber, Wolfgang A Molecular imaging of tumor metabolism has gained considerable interest, since preclinical studies have indicated a close relationship between the activation of various oncogenes and alterations of cellular metabolism. Furthermore, several clinical trials have shown that metabolic imaging can significantly impact patient management by improving tumor staging, restaging, radiation treatment planning, and monitoring of tumor response to therapy. In this...

2008-06-25 03:02:02

By Tumeh, Paul C Radu, Caius G; Ribas, Antoni Immune system activation can be elicited in viral infections, active immunization, or cancer immunotherapy, leading to the final common phenotype of increased glycolytic use by immune cells and subsequent detection by ^sup 18^F-FDG PET. Because ^sup 18^F-FDG is also used in baseline staging PET/CT scans and in tumor response assessment, physicians are faced with a unique challenge when evaluating tumor response in patients receiving cancer...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related